Header Logo

Sheilah Clayton

Concepts (53)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
4
2017
167
0.610
Why?
Oncology Nursing
1
2011
1
0.420
Why?
Nurse's Role
1
2011
6
0.420
Why?
Clinical Trials as Topic
1
2011
19
0.420
Why?
Minority Groups
1
2011
40
0.410
Why?
Health Services Accessibility
1
2011
61
0.410
Why?
Receptor, ErbB-2
2
2017
28
0.230
Why?
Wnt3 Protein
1
2017
6
0.150
Why?
Transforming Growth Factor beta
1
2017
81
0.140
Why?
Female
4
2017
1733
0.130
Why?
Humans
4
2017
2493
0.110
Why?
Nurse-Patient Relations
1
2011
1
0.110
Why?
Academic Medical Centers
1
2011
6
0.110
Why?
Patient Selection
1
2011
13
0.110
Why?
Patient Participation
1
2011
10
0.110
Why?
California
1
2011
93
0.100
Why?
Proto-Oncogene Proteins c-akt
1
2008
25
0.080
Why?
Amino Acid Transport Systems
1
2006
3
0.080
Why?
Amino Acids
1
2006
16
0.080
Why?
Antineoplastic Agents, Phytogenic
1
2006
7
0.080
Why?
Paclitaxel
1
2006
13
0.070
Why?
Apoptosis
1
2006
162
0.070
Why?
Cell Line, Tumor
2
2017
138
0.050
Why?
Thiosemicarbazones
1
2017
4
0.040
Why?
Receptors, Transforming Growth Factor beta
1
2017
5
0.040
Why?
Twist-Related Protein 1
1
2017
6
0.040
Why?
beta Catenin
1
2017
16
0.040
Why?
Pyrazoles
1
2017
9
0.040
Why?
Wnt Signaling Pathway
1
2017
9
0.040
Why?
Trastuzumab
1
2017
20
0.040
Why?
Epithelial-Mesenchymal Transition
1
2017
24
0.040
Why?
Vascular Endothelial Growth Factor A
1
2017
30
0.040
Why?
Drug Resistance, Neoplasm
1
2017
27
0.040
Why?
Gene Expression Regulation, Neoplastic
1
2017
77
0.040
Why?
Disease-Free Survival
1
2008
12
0.020
Why?
Survival Analysis
1
2008
28
0.020
Why?
Immunohistochemistry
1
2008
133
0.020
Why?
Antibiotics, Antineoplastic
1
2006
4
0.020
Why?
Alanine
1
2006
4
0.020
Why?
Ethylmaleimide
1
2006
6
0.020
Why?
Maleimides
1
2006
6
0.020
Why?
Caspase Inhibitors
1
2006
5
0.020
Why?
Starvation
1
2006
5
0.020
Why?
Doxorubicin
1
2006
10
0.020
Why?
In Situ Nick-End Labeling
1
2006
19
0.020
Why?
Caspases
1
2006
21
0.020
Why?
Sodium
1
2006
28
0.020
Why?
Enzyme Inhibitors
1
2006
45
0.020
Why?
Dose-Response Relationship, Drug
1
2006
118
0.020
Why?
Gene Expression Regulation
1
2006
93
0.020
Why?
Cell Proliferation
1
2006
110
0.020
Why?
Middle Aged
1
2008
799
0.020
Why?
African Americans
1
2008
272
0.020
Why?
Clayton's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (53)
Explore
_
Co-Authors (4)
Explore
_
Similar People (59)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_